The development of a systemic inflammatory response in cancer patients is characterized by elevated CRP and hypoalbuminemia, which has a substantial impact on survival due to accelerated protein breakdown and direct catabolic effects on skeletal muscles and other host tissues. Here, CRP is linked to cancer.